Synthesis and
<i>In Vitro</i>
Anticancer Evaluation of Some Benzimidazolium Salts
作者:Senem Akkoç、Veysel Kayser、İlhan Özer İlhan
DOI:10.1002/jhet.3687
日期:2019.10
A series of benzimidazolium salts having 2‐cyanobenzyl (2–6), 2‐(4‐nitrophenyl)ethyl (7–10), (1,3‐dioxoisoindolin‐2‐yl)butyl (11–17) or N‐methylphthalimide (18–22) substitution were synthesized and characterized by spectroscopic and analytical techniques. The in vitro cytotoxic activity of these salts was tested against human colon cancer (DLD‐1), human breast cancer (MDA‐MB‐231), and normal human
一系列苯并咪唑盐的具有2-氰基苄基(2 - 6),2-(4-硝基苯基)乙基(7 - 10),(1,3- dioxoisoindolin -2-基)丁基(11 - 17)或ñ -methylphthalimide (18 - 22)取代被合成和表征通过光谱和分析技术。在体外使用MTT分析方法测试了这些盐对人结肠癌(DLD-1),人乳腺癌(MDA-MB-231)和正常人非癌胚肾(HEK-293T)细胞系的细胞毒性活性。通过共聚焦显微镜确定细胞的存活率。大多数新合成的化合物中,用化合物除外2,3,8,11,12,和17,所显示的高细胞毒性活性针对癌性细胞。实际上,化合物6和7对MDA-MB-231细胞的表现优于阳性对照药物顺铂和白消安。因此,化合物6和7可被视为抗癌候选药物的进一步发展。